降钙素基因相关肽 Calcitonin gene-related peptide (CGRP) is a fascinating neuropeptide that plays a significant role in various physiological processes, most notably in vasodilation and the pathophysiology of migraines. This 37-amino acid peptide, belonging to the calcitonin family, is widely distributed throughout the human body, originating from neurons in both the central and peripheral nervous systems.作者:J Ailani·2022·被引用次数:61—Calcitonin gene-related peptide (CGRP) is involved in several of the pathophysiologic processes underpinning migraine attacks. Its discovery over 30 years ago has led to extensive research, revealing its intricate involvement in inflammation, nerve injury, and pain signaling.
The Molecular Identity and Production of CGRP
Calcitonin gene-related peptide is encoded by the CALCA and CALCB genes, resulting in two primary isoforms: α-CGRP and β-CGRP. The production of CGRP is a result of alternative RNA processing.Calcitonin Gene Related Peptide (rat) is a potent, long-lasting vasodilator; activation of CGRP receptors on pancreatic β-cells increases plasma levels of ... It is a potent vasodilator peptide released from sensory nerves. While it is not the primary regulator of blood pressure or hemodynamics in general, its localized effects on blood vessels are significant. For instance, CGRP acts to vasodilate cranial arterioles but not the venous sinuses, highlighting its specific role in cerebrovascular regulation. Research has also explored its presence and function in specific tissues, such as its activation of CGRP receptors on pancreatic β-cells, which can increase plasma levels of certain hormonesCalcitonin Gene-Related Peptide Antibodies (CGRP) for ....
CGRP's Role in Migraine Pathophysiology
The association between calcitonin gene-related peptide and migraine headaches is a prominent area of scientific investigation. When CGRP is released, it can trigger intense inflammation in the meninges, the protective coverings of the brain.作者:A Bonura·2023·被引用次数:23—Thecalcitonin gene-related peptide (CGRP) is a neuropeptide widely distributed throughout the human body. While primarily recognized as a ... For a majority of migraine sufferers, this inflammatory response mediated by CGRP is a key factor in the experience of pain.Calcitonin Gene-Related Peptide (CGRP): Novel Biology ... This understanding has paved the way for novel therapeutic approaches.2023年4月11日—Published data pertaining tocalcitonin gene-related peptide (CGRP) concentrations in human plasma are inconsistent.
Therapeutic Innovations Targeting CGRP
The deep understanding of CGRP's involvement in migraine has led to the development of innovative treatmentsCalcitonin Gene-Related Peptide Antibodies (CGRP) for .... CGRP inhibitors represent a new class of medications specifically designed to combat migraines and chronic headachesCalcitonin gene related peptide in migraine. These drugs work by targeting and blocking the action of CGRP.
There are two main categories of CGRP inhibitors:
* Monoclonal Antibodies: These are biological therapies that target and block calcitonin gene-related peptide (CGRP) itself or its receptor. Examples include antibodies directed against human calcitonin-gene related peptide, offering a targeted approach to prevent migraine attacks.Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide found in sensory and motor neurons throughout the central and peripheral nervous systems ...
* Receptor Antagonists (Gepants): These are small molecule drugs that act as antagonists of the calcitonin gene-related peptide receptor. Calcitonin gene-related peptide receptor antagonists, commonly known as gepants, are a class of drugs that effectively block the signaling pathway of CGRP.
These CGRP inhibitors have emerged as a promising new tool in the prevention of migraine, offering hope to individuals who have historically struggled with effective treatment options. The development of CGRP antibodies and gepants signifies a significant advancement in neurology, driven by decades of translational research into the physiology and pathophysiology of this crucial neuropeptide.
Beyond Migraine: Other Functions of CGRP
While its role in migraine is significant, the influence of calcitonin gene-related peptide extends furtherCalcitonin gene-related peptide. It is involved in central and peripheral sensitization during inflammation and nerve injury. Its potent vasodilatory properties are also recognized in other contexts, such as its effects on the heart, though this area has historically received less research attention compared to its role in migrainesCalcitonin gene-related peptide (CGRP) is defined as a neuropeptide encoded by the CALCA and CALCB genes, resulting in two forms, α-CGRP and β-CGRP, .... Studies have also investigated the impact of nutrition and calcitonin gene-related peptide (CGRP) in migraine, suggesting potential dietary influences on its activity.
Ongoing Research and Future Directions
Research into calcitonin gene-related peptide continues to evolve.Calcitonin gene-related peptide (CGRP) is involved in central and peripheral sensitization during inflammation and nerve injury. Scientists are exploring its systemic effects, its interactions with other peptides like amylin (AMY), adrenomedullin (AM), and intermedin/adrenomedullin-2 (IMD), and its specific roles in various bodily functions. The detection and quantification of CGRP concentrations in human plasma are ongoing areas of study, with published data sometimes showing inconsistencies, underscoring the need for rigorous methodologies. The exploration of CGRP receptor mechanisms and the development of CGRP receptor agonists also represent active fields of research, potentially leading to further therapeutic breakthroughs.
In summary, calcitonin gene-related peptide is a vital neuropeptide with profound implications for vascular health and neurological conditions like migraineCalcitonin Gene-Related Peptide (CGRP) Inhibitors. The ongoing scientific endeavors to unravel its complexities promise continued advancements in both our understanding of human physiology and the development of more effective therapeutic interventions.Calcitonin-gene related peptide(CGRP), amylin (AMY), adrenomedullin (AM),calcitoninreceptor-stimulating peptide (CRSP) and intermedin/adrenomedullin-2 (IMD/ ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.